Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3)
Jérôme Feldmann(Inserm), Geneviève de Saint Basile(Inserm), Gaëlle Chédeville(Hôpital Necker-Enfants Malades), Nathalie Lambert(Hôpital Necker-Enfants Malades), Véronique Minard‐Colin(Inserm), Graça Raposo(Centre National de la Recherche Scientifique), E Vilmer(Hôpital Robert-Debré), Isabelle Callebaut(Centre National de la Recherche Scientifique), Hannah Tamary(Tel Aviv University), Stéphanie Certain(Inserm), Stéphane Blanche(Délégation Paris 5), Delphine Bacq(Centre National de Recherche en Génomique Humaine), O Marie(Hôpital Necker-Enfants Malades), Françoise Le Deist(Centre National de la Recherche Scientifique), Alain Fischer(Inserm)
Cited by 927
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k